Manufacturing Chemist Stand Side with Almac Group

Published: 21-Nov-2024 Featured companies: Almac Group
Manufacturing

We discover what exhibitors at CPHI Milan 2024 are showcasing LIVE!

Sponsored by Almac Group

In this interview, Manufacturing Chemist Stand Side speaks with Almac Group at CPHI Milan 2024.

For more interviews with leading companies from across the manufacturing pharmaceuticals industry, visit our YouTube channel and hit subscribe.

 

 

Manufacturing Chemist Stand Side...

"Manufacturing Chemist Stand Side" is a series of exclusive video interviews with leading companies in the pharmaceutical industry, conducted during key market events by our award-winning B2B team.

For more information on how you can be part of "Manufacturing Chemist Stand Side" contact Don Phares on +44 207 193 3219 or via email: don@hpcimedia.com.

 

Featured companies

The Almac Group is an established contract development and manufacturing organisation which provides an extensive range of integrated services to the pharmaceutical and biotech...
See more

You may also like

Manufacturing

Almac’s Charnwood facility receives FDA approval for oral dose development and manufacturing

Read more
The facility, which focuses on the manufacture of high potency oral dosage forms, has been approved for use by the FDA

Trending Articles

  1. ACG expands global footprint with new capsule manufacturing facility in Thailand New capsule manufacturing facility in Rayong, Thailand, is strategically positioned to serve key Asian markets
  2. Get ahead in the pharmaceutical industry with a Manufacturing Chemist subscription With a Manufacturing Chemist subscription you receive exclusive access to the latest news, technical insights, regulatory updates, and market intelligence
  3. Scinai Immunotherapeutics establishes Delaware-based US CDMO subsidiary The biopharmaceutical company now operates contract development and manufacturing services in both Jerusalem and Delaware
  4. TekniPlex Healthcare to showcase expanded capacity and sustainability solutions at Pharmapack Company highlights EU-based advancements in injection blow molding, multilayer blown films, and sustainable blister packaging
  5. Novo Nordisk invests DKK 8.5bn into new Danish modular production site This is the first time this century that Novo Nordisk has invested into its Danish production capabilities, with the site being capable of manufacturing product types within rare disease indications

Relevant companies

See more

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Manufacturing

Almac’s Charnwood facility receives FDA approval for oral dose development and manufacturing

The facility, which focuses on the manufacture of high potency oral dosage forms, has been approved for use by the FDA
Manufacturing

Almac Sciences awarded Life Sciences Innovative Manufacturing Fund grant

Grant awarded to support the expansion of Almac’s small molecule API manufacturing plant
Manufacturing

BGEN awarded small molecule production facility contract by Almac Sciences

This build will enhance Almac Sciences' active pharmaceutical ingredient (API) production capabilities
Manufacturing

Almac Group releases details of $97m HQ expansion in Northern Ireland

The £80 million expansion has been designed by the pharmaceutical services provider to provide a 140,000 sqft capacity increase for development and manufacturing facilities
Manufacturing

Asynt and Almac team up on bespoke reactor vessels

The two companies have teamed up design and supply a range of bespoke reactor vessels, highlighting the benefits of utilising Asynt's lab vessels to streamline Almac Sciences' scale-up process
Manufacturing

Almac updates software with new content for cancer research

The updates include 16 new gene expression signatures across the Hallmarks of Cancer, improved functionality with online data access and simplified reporting
Manufacturing

Almac launches IXRS3 partnership network

“Managing a mix of technologies throughout the course of a clinical trial is a common pain point for sponsors and service providers."
Subscribe now